System1 Biosciences
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1554 Grove St, San Francisco, California...Phone Number
(929) 575-5579Website
system1.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About System1 Biosciences
System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. These deep phenotypes are exploited to identify novel therapeutic targets and drug treatments.Explore more
System1 Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is System1 Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at System1 Biosciences
Check out if System1 Biosciences is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if System1 Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if System1 Biosciences had a recent Job posting/layoffs
Funding: Get notified immidiatlly once System1 Biosciences has new funding data
System1 Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on System1 Biosciences recently announced quarterly report
Product Launch: Get notified when System1 Biosciences launches new products
Recommended Actions
Reach out to Masked Content who joined System1 Biosciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to System1 Biosciences
Compare insights from companies similar to System1 Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
System1 Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
System1 Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about System1 Biosciences.
System1 Biosciences financials insights
Gather financial insights about System1 Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$25M
2020
Debt
$350K
System1 Biosciences Tech Stack
A closer look at the technologies used by System1 Biosciences
Most Recent Scoops
New Hire
Executive Move
Daniel Chao has been named Chief Executive Officer.
Funding
System1 Biosciences has received an SBA PPP loan for $350,000-1 million from Silicon Valley Bank.
Executive Move
Partnership, Board of Directors
Executive Move
Partnership, Board of Directors
Funding
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding System1 Biosciences
Sign Up For FreeTo access detailed company insights
System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoid scien... Read More
